Insider Purchases of Penny Stocks -
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-04-22 | ACRT | Advanced Credit Technologies Inc | Schuette Rex S | Dir | P - Purchase | $0.10 | +625,000 | 2,587,500 | +32% | +$62,500 | ||||||
| DM | 2019-03-28 | ADIL | Adial Pharmaceuticals, Inc. | Johnson Bankole A. | Chief Medical Officer, 10% | P - Purchase | $3.29 | +73,100 | 1,371,287 | +6% | +$240,609 | |||||
2019-04-10 | ADXS | Advaxis, Inc. | Appel Roni | Dir | P - Purchase | $3.80 | +3,000 | 13,476 | +29% | +$11,391 | ||||||
| A | 2019-03-25 | AGRX | Agile Therapeutics Inc | Altomari Alfred | CEO | P - Purchase | $1.54 | +25,000 | 238,568 | +12% | +$38,500 | |||||
2019-03-29 | AGRX | Agile Therapeutics Inc | Lele Abhijeet J | Dir | P - Purchase | $1.54 | +20,000 | 37,949 | +111% | +$30,800 | ||||||
| D | 2019-04-15 | AMRS | Amyris, Inc. | Doerr L John | Dir, 10% | P - Purchase | $2.87 | +6,732,369 | 14,853,726 | +83% | +$19,321,899 | |||||
| D | 2019-03-29 | ANH | Anworth Mortgage Asset Corp | Mielle Dominique | Dir | P - Purchase | $4.05 | +30,000 | 30,000 | New | +$121,500 | |||||
2019-04-22 | ANIX | Anixa Biosciences Inc | Titterton Lewis H Jr | Dir | P - Purchase | $4.09 | +50,000 | 891,544 | +6% | +$204,500 | ||||||
2019-04-24 | ANIX | Anixa Biosciences Inc | Kumar Amit | CEO | P - Purchase | $4.27 | +10,000 | 160,000 | +7% | +$42,700 | ||||||
2019-04-18 | APTO | Aptose Biosciences Inc. | Rice William G. | Chair, Pres, CEO | P - Purchase | $1.85 | +10,000 | 153,014 | +7% | +$18,507 | ||||||
2019-04-02 | ASPU | Aspen Group, Inc. | Maclean Malcolm F IV | Dir | P - Purchase | $4.89 | +2,100 | 673,551 | 0% | +$10,270 | ||||||
| A | 2019-04-18 | AVCO | Avalon Globocare Corp. | Lu Wenzhao | Dir, 10% | P - Purchase | $1.00 | +2,000,000 | 27,900,000 | +8% | +$2,000,000 | |||||
| D | 2019-04-08 | AVEO | Aveo Pharmaceuticals Inc | Growth Equity Opportunities Fund Iv, LLC | 10% | P - Purchase | $1.14 | +4,347,827 | 25,243,865 | +21% | +$4,956,523 | |||||
| D | 2019-04-08 | AVEO | Aveo Pharmaceuticals Inc | Sonsini Peter W. | 10% | P - Purchase | $1.14 | +4,347,827 | 25,243,865 | +21% | +$4,956,523 | |||||
| D | 2019-04-08 | AVEO | Aveo Pharmaceuticals Inc | Sandell Scott D | 10% | P - Purchase | $1.14 | +4,347,827 | 25,243,865 | +21% | +$4,956,523 | |||||
| D | 2019-04-08 | AVEO | Aveo Pharmaceuticals Inc | Mott David M | 10% | P - Purchase | $1.14 | +4,347,827 | 25,243,865 | +21% | +$4,956,523 | |||||
| D | 2019-04-08 | AVEO | Aveo Pharmaceuticals Inc | Makower Joshua | 10% | P - Purchase | $1.14 | +4,347,827 | 25,243,865 | +21% | +$4,956,523 | |||||
| D | 2019-04-08 | AVEO | Aveo Pharmaceuticals Inc | Makhzoumi Mohamad | 10% | P - Purchase | $1.14 | +4,347,827 | 25,243,865 | +21% | +$4,956,523 | |||||
| D | 2019-04-08 | AVEO | Aveo Pharmaceuticals Inc | Florence Anthony A. Jr. | 10% | P - Purchase | $1.14 | +4,347,827 | 25,243,865 | +21% | +$4,956,523 | |||||
| D | 2019-04-08 | AVEO | Aveo Pharmaceuticals Inc | Baskett Forest | 10% | P - Purchase | $1.14 | +4,347,827 | 25,243,865 | +21% | +$4,956,523 | |||||
| D | 2019-04-08 | AVEO | Aveo Pharmaceuticals Inc | Barris Peter J | 10% | P - Purchase | $1.14 | +4,347,827 | 25,243,865 | +21% | +$4,956,523 | |||||
| D | 2019-03-15 | BASA | Basanite, Inc. | Sallarulo Paul M. | Dir | P - Purchase | $0.05 | +2,000,000 | 3,583,333 | +126% | +$100,000 | |||||
| M | 2019-04-04 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $1.95 | +15,425 | 3,231,807 | 0% | +$30,005 | |||||
| M | 2019-04-01 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $1.88 | +11,173 | 3,216,382 | 0% | +$20,977 | |||||
| M | 2019-04-11 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.13 | +16,192 | 3,272,289 | 0% | +$34,456 | |||||
| M | 2019-04-22 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.04 | +16,088 | 3,314,273 | 0% | +$32,837 | |||||
2019-04-18 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.05 | +6,174 | 3,298,185 | 0% | +$12,630 | ||||||
| M | 2019-04-15 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.05 | +19,722 | 3,292,011 | +1% | +$40,443 | |||||
| M | 2019-04-08 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.06 | +24,290 | 3,256,097 | +1% | +$50,093 | |||||
| D | 2019-04-03 | CTXR | Citius Pharmaceuticals, Inc. | Mazur Leonard L | Exec COB, 10% | P - Purchase | $1.54 | +1,165,048 | 8,020,643 | +17% | +$1,799,999 | |||||
| D | 2019-04-03 | CTXR | Citius Pharmaceuticals, Inc. | Holubiak Myron Z | Pres, CEO, 10% | P - Purchase | $1.54 | +129,450 | 1,433,646 | +10% | +$200,000 | |||||
2019-03-27 | CVRS | Corindus Vascular Robotics, Inc. | Cannon Louis A | Dir | P - Purchase | $1.80 | +10,000 | 8,392,551 | 0% | +$18,000 | ||||||
2019-04-11 | DARE | Dare Bioscience, Inc. | Hawley Roger | Dir | P - Purchase | $1.10 | +454,545 | 1,084,956 | +72% | +$500,000 | ||||||
2019-04-22 | DXLG | Destination Xl Group, Inc. | Conacher Lionel F. | Dir | P - Purchase | $2.26 | +22,000 | 37,998 | +138% | +$49,727 | ||||||
2019-04-02 | EGLE | Eagle Bulk Shipping Inc. | Oaktree Capital Group Holdings Gp, LLC | 10% | P - Purchase | $4.69 | +32,516 | 26,409,985 | 0% | +$152,500 | ||||||
| M | 2019-03-27 | EGLE | Eagle Bulk Shipping Inc. | Oaktree Capital Group Holdings Gp, LLC | 10% | P - Purchase | $4.54 | +157,931 | 52,635,364 | 0% | +$716,292 | |||||
| M | 2019-03-27 | EYEG | Eyegate Pharmaceuticals Inc | Armistice Capital, LLC | Dir, 10% | P - Purchase | $0.32 | +549,647 | 35,625,000 | +2% | +$175,216 | |||||
2019-03-29 | EYPT | Eyepoint Pharmaceuticals, Inc. | Lurker Nancy | Pres, CEO | P - Purchase | $1.76 | +28,500 | 240,200 | +13% | +$50,246 | ||||||
2019-03-29 | EYPT | Eyepoint Pharmaceuticals, Inc. | Godshall Douglas Evan | Dir | P - Purchase | $1.75 | +17,000 | 29,500 | +136% | +$29,784 | ||||||
2019-04-05 | GALT | Galectin Therapeutics Inc | Uihlein Richard E | Dir, 10% | P - Purchase | $4.81 | +21,000 | 2,627,789 | +1% | +$100,972 | ||||||
2019-04-09 | GALT | Galectin Therapeutics Inc | Uihlein Richard E | Dir, 10% | P - Purchase | $4.82 | +20,700 | 2,648,489 | +1% | +$99,851 | ||||||
2019-04-11 | GTE | Gran Tierra Energy Inc. | Gmt Capital Corp | 10% | P - Purchase | $2.46 | +337,400 | 74,557,386 | 0% | +$830,004 | ||||||
2019-04-08 | GTE | Gran Tierra Energy Inc. | Gmt Capital Corp | 10% | P - Purchase | $2.49 | +100,000 | 74,219,986 | 0% | +$249,000 | ||||||
| M | 2019-04-18 | HIO | Western Asset High Income Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% | P - Purchase | $4.94 | +71,576 | 14,100,332 | +1% | +$353,540 | |||||
| M | 2019-04-03 | HIO | Western Asset High Income Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% | P - Purchase | $4.90 | +74,951 | 14,016,940 | +1% | +$366,969 | |||||
| M | 2019-04-01 | HIO | Western Asset High Income Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% | P - Purchase | $4.86 | +40,289 | 13,941,989 | 0% | +$195,782 | |||||
2019-04-15 | HIO | Western Asset High Income Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% | P - Purchase | $4.94 | +11,816 | 14,028,756 | 0% | +$58,371 | ||||||
| A | 2019-03-12 | HJLI | Hancock Jaffe Laboratories, Inc. | Berman Robert Andrew | CEO | P - Purchase | $1.36 | +18,382 | 18,382 | New | +$25,000 | |||||
| M | 2019-03-28 | JMP | Jmp Group LLC | Jolson Joseph A | CEO, 10% | P - Purchase | $3.89 | +54,169 | 6,599,185 | +1% | +$210,583 | |||||
| M | 2019-03-25 | JMP | Jmp Group LLC | Jolson Joseph A | CEO, 10% | P - Purchase | $3.99 | +31,469 | 6,545,016 | 0% | +$125,554 | |||||
| M | 2019-04-16 | JMP | Jmp Group LLC | Jolson Joseph A | CEO, 10% | P - Purchase | $3.99 | +16,306 | 6,616,131 | 0% | +$65,014 | |||||
| A | 2019-03-12 | JMP | Jmp Group LLC | Jolson Joseph A | CEO, 10% | P - Purchase | $4.05 | +3,150 | 4,960,730 | 0% | +$12,748 | |||||
| M | 2019-03-28 | KFS | Kingsway Financial Services Inc | Stilwell Joseph | Dir, 10% | P - Purchase | $3.01 | +135,341 | 1,615,566 | +9% | +$406,909 | |||||
| M | 2019-03-26 | KFS | Kingsway Financial Services Inc | Stilwell Joseph | Dir, 10% | P - Purchase | $2.70 | +133,682 | 1,547,566 | +9% | +$360,745 | |||||
| M | 2019-03-25 | LGCY | Legacy Reserves Inc. | Baines Creek Capital, LLC | 10% | P - Purchase | $0.50 | +252,514 | 26,749,188 | +1% | +$126,257 | |||||
2019-04-09 | LLEX | Lilis Energy, Inc. | Daches Joseph C | Pres, CFO | P - Purchase | $1.25 | +10,000 | 1,169,560 | +1% | +$12,500 | ||||||
2019-04-11 | LONE | Lonestar Resources Us Inc. | Bracken Frank D III | CEO | P - Purchase | $4.42 | +10,000 | 201,284 | +5% | +$44,175 | ||||||
2019-04-15 | LTS | Ladenburg Thalmann Financial Services Inc. | Lampen Richard | CEO, Pres, COB | P - Purchase | $3.43 | +10,000 | 3,086,204 | 0% | +$34,301 | ||||||
2019-04-11 | LTS | Ladenburg Thalmann Financial Services Inc. | Zeitchick Mark | EVP | P - Purchase | $3.38 | +10,000 | 4,058,546 | 0% | +$33,768 | ||||||
2019-04-10 | LTS | Ladenburg Thalmann Financial Services Inc. | Lampen Richard | CEO, Pres, COB | P - Purchase | $3.24 | +20,000 | 3,076,204 | +1% | +$64,740 | ||||||
2019-04-05 | LTS | Ladenburg Thalmann Financial Services Inc. | Malamed Adam Scott | EVP, COO | P - Purchase | $2.93 | +15,000 | 1,487,541 | +1% | +$43,988 | ||||||
2019-04-10 | LTS | Ladenburg Thalmann Financial Services Inc. | Liebowitz Michael | Dir | P - Purchase | $3.23 | +12,902 | 196,398 | +7% | +$41,733 | ||||||
2019-04-05 | LTS | Ladenburg Thalmann Financial Services Inc. | Davis Glenn C | Dir | P - Purchase | $2.93 | +5,000 | 39,000 | +15% | +$14,642 | ||||||
2019-04-12 | LTS | Ladenburg Thalmann Financial Services Inc. | Malamed Adam Scott | EVP, COO | P - Purchase | $3.46 | +10,000 | 1,497,541 | +1% | +$34,600 | ||||||
2019-04-05 | LTS | Ladenburg Thalmann Financial Services Inc. | Liebowitz Michael | Dir | P - Purchase | $2.92 | +10,000 | 183,496 | +6% | +$29,200 | ||||||
2019-04-15 | LTS | Ladenburg Thalmann Financial Services Inc. | Malamed Adam Scott | EVP, COO | P - Purchase | $3.47 | +15,000 | 1,512,541 | +1% | +$52,124 | ||||||
2019-03-28 | MDCA | Mdc Partners Inc | Rogers Desiree G | Dir | P - Purchase | $2.17 | +23,820 | 43,800 | +119% | +$51,689 | ||||||
| M | 2019-03-27 | MHLD | Maiden Holdings, Ltd. | Neuberger Yehuda | Dir | P - Purchase | $0.80 | +200,000 | 271,000 | +282% | +$160,367 | |||||
| M | 2019-04-02 | MNI | McClatchy Co | Chatham Asset Management, LLC | 10% | P - Purchase | $4.58 | +10,583 | 1,286,964 | +1% | +$48,440 | |||||
| M | 2019-03-29 | MNI | McClatchy Co | Chatham Asset Management, LLC | 10% | P - Purchase | $4.98 | +67,677 | 1,276,381 | +6% | +$337,069 | |||||
| M | 2019-03-06 | MYDP | Dougherty'S Pharmacy, Inc. | Phillips Troy | Dir, 10% | P - Purchase | $0.10 | +118,750 | 3,898,493 | +3% | +$12,047 | |||||
2019-04-18 | MYDP | Dougherty'S Pharmacy, Inc. | Phillips Troy | Dir, 10% | P - Purchase | $0.17 | +100,000 | 3,998,493 | +3% | +$17,250 | ||||||
2019-03-27 | MYOS | Myos Rens Technology Inc. | Mannello Joseph | CEO, 10% | P - Purchase | $1.46 | +171,233 | 689,210 | +33% | +$250,000 | ||||||
2019-03-27 | MYOS | Myos Rens Technology Inc. | Pechock Christopher | Dir | P - Purchase | $1.46 | +34,247 | 261,157 | +15% | +$50,001 | ||||||
2019-04-01 | N.A. | South Dakota Soybean Processors LLC | Skinner Ned | Dir | P - Purchase | $3.28 | +17,000 | 173,250 | +11% | +$55,770 | ||||||
2019-03-27 | NVAX | Novavax Inc | King Rachel K. | Dir | P - Purchase | $0.53 | +86,000 | 64,000 | -391% | +$45,563 | ||||||
2019-04-22 | NWPP | New Peoples Bankshares Inc | Cox John D | Dir | P - Purchase | $1.80 | +10,815 | 459,376 | +2% | +$19,467 | ||||||
2019-03-28 | OPGN | Opgen Inc | Jones Evan/ Fa | CEO | P - Purchase | $0.60 | +417,000 | 649,384 | +179% | +$250,200 | ||||||
2019-04-09 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.51 | +10,000 | 213,059,633 | 0% | +$25,093 | ||||||
2019-04-15 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.46 | +10,000 | 213,139,633 | 0% | +$24,650 | ||||||
2019-04-11 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.49 | +30,000 | 213,109,633 | 0% | +$74,561 | ||||||
2019-04-22 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.32 | +80,000 | 213,279,633 | 0% | +$185,613 | ||||||
2019-04-17 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.42 | +50,000 | 213,199,633 | 0% | +$120,953 | ||||||
2019-04-02 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.53 | +40,000 | 213,029,633 | 0% | +$101,187 | ||||||
2019-04-10 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.53 | +20,000 | 213,079,633 | 0% | +$50,602 | ||||||
2019-04-12 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.50 | +20,000 | 213,129,633 | 0% | +$49,994 | ||||||
2019-04-16 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.50 | +10,000 | 213,149,633 | 0% | +$24,997 | ||||||
2019-03-27 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.49 | +100,000 | 212,969,633 | 0% | +$248,646 | ||||||
2019-04-04 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.53 | +20,000 | 213,049,633 | 0% | +$50,627 | ||||||
2019-04-01 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $2.58 | +20,000 | 212,989,633 | 0% | +$51,560 | ||||||
2019-03-27 | OSS | One Stop Systems, Inc. | Raun David | Dir | P - Purchase | $2.03 | +7,500 | 20,000 | +60% | +$15,250 | ||||||
| M | 2019-03-28 | OXBR | Oxbridge Re Holdings Ltd | Martin Allan S. | 10% | P - Purchase | $1.06 | +56,415 | 423,334 | +15% | +$59,786 | |||||
| DM | 2019-04-01 | PKTX | Protokinetix, Inc. | Smith Clarence Edward | Pres, CEO, 10% | P - Purchase | $0.06 | +3,052,576 | 69,277,434 | +5% | +$172,388 | |||||
| D | 2019-04-08 | PSTI | Pluristem Therapeutics Inc | Ben-Yoram Israel | Dir | P - Purchase | $0.70 | +71,429 | 798,485 | +10% | +$50,000 | |||||
| D | 2019-04-08 | PSTI | Pluristem Therapeutics Inc | Kwiat Moria | Dir | P - Purchase | $0.70 | +28,571 | 373,571 | +8% | +$20,000 | |||||
| D | 2019-04-08 | PSTI | Pluristem Therapeutics Inc | Shorrer Doron | Dir | P - Purchase | $0.70 | +14,286 | 897,244 | +2% | +$10,000 | |||||
| D | 2019-04-08 | PSTI | Pluristem Therapeutics Inc | Braun Isaac | Dir | P - Purchase | $0.70 | +50,000 | 636,208 | +9% | +$35,000 | |||||
| D | 2019-04-08 | PSTI | Pluristem Therapeutics Inc | Aberman Zami | Co-CEO, COB | P - Purchase | $0.70 | +71,429 | 5,051,127 | +1% | +$50,000 | |||||
| D | 2019-04-08 | PSTI | Pluristem Therapeutics Inc | Yanay Yaky | Co-CEO, Pres | P - Purchase | $0.70 | +71,429 | 4,319,544 | +2% | +$50,000 | |||||
| M | 2019-04-03 | RMBL | Rumbleon, Inc. | Dixon Denmar John | Dir | P - Purchase | $4.77 | +50,415 | 1,193,473 | +4% | +$240,249 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |